HIV-1-specific immune responses in subjects who temporarily contain virus replication after discontinuation of highly active antiretroviral therapy (Q33853859)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	HIV-1-specific immune responses in subjects who temporarily contain virus replication after discontinuation of highly active antiretroviral therapy	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

HIV-1-specific immune responses in subjects who temporarily contain virus replication after discontinuation of highly active antiretroviral therapy (English)

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

anti-retroviral agent

0 references

Sebastian Bonhoeffer

6

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Alexandra Trkola

object named as

A Trkola

3

0 references

author name string

G M Ortiz

1

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

D F Nixon

2

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

J Binley

4

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

X Jin

5

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

P J Kuebler

7

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

S M Donahoe

8

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

M A Demoitie

9

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

W M Kakimoto

10

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

T Ketas

11

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

B Clas

12

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

J J Heymann

13

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

L Zhang

14

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Y Cao

15

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

A Hurley

16

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

J P Moore

17

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

D D Ho

18

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

M Markowitz

19

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

language of work or name

0 references

publication date

1 September 1999

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Journal of Clinical Investigation

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

104

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

6

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

R13-8

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

A recombinant vaccinia virus based ELISPOT assay detects high frequencies of Pol-specific CD8 T cells in HIV-1-positive individuals

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=408442

5 July 2018

Quantifying residual HIV-1 replication in patients receiving combination antiretroviral therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=408442

5 July 2018

Latent infection of CD4+ T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=408442

5 July 2018

Frequency of class I HLA-restricted anti-HIV CD8+ T cells in individuals receiving highly active antiretroviral therapy (HAART).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=408442

5 July 2018

Viral immune evasion due to persistence of activated T cells without effector function

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=408442

5 July 2018

Decay kinetics of human immunodeficiency virus-specific effector cytotoxic T lymphocytes after combination antiretroviral therapy.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=408442

5 July 2018

Longitudinal and cross-sectional analysis of cytotoxic T lymphocyte responses and their relationship to vertical human immunodeficiency virus transmission. ARIEL Project Investigators

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=408442

5 July 2018

HIV-1 antigen-specific and -nonspecific B cell responses are sensitive to combination antiretroviral therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=408442

5 July 2018

Immunological and virological analyses of persons infected by human immunodeficiency virus type 1 while participating in trials of recombinant gp120 subunit vaccines

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=408442

5 July 2018

Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=408442

5 July 2018

Vigorous HIV-1-specific CD4+ T cell responses associated with control of viremia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=408442

5 July 2018

Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=408442

5 July 2018

Recovery of replication-competent HIV despite prolonged suppression of plasma viremia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=408442

5 July 2018

Positive selection of HIV-1 cytotoxic T lymphocyte escape variants during primary infection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=408442

5 July 2018

Antiviral pressure exerted by HIV-1-specific cytotoxic T lymphocytes (CTLs) during primary infection demonstrated by rapid selection of CTL escape virus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=408442

5 July 2018

Serum HIV-1 RNA levels and time to development of AIDS in the Multicenter Hemophilia Cohort Study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=408442

5 July 2018

Prognosis in HIV-1 infection predicted by the quantity of virus in plasma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=408442

5 July 2018

Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=408442

5 July 2018

Virus-specific CD8+ cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=408442

5 July 2018

Molecular tracking of an Human Immunodeficiency Virus nef specific cytotoxic T-cell clone shows persistence of clone-specific T-cell receptor DNA but not mRNA following early combination antiretroviral therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=408442

29 October 2018

The effect of commencing combination antiretroviral therapy soon after human immunodeficiency virus type 1 infection on viral replication and antiviral immune responses

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=408442

29 October 2018

Rebound of HIV-1 viral load after suppression to very low levels

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=408442

29 October 2018

Characterization of long-term survivors of human immunodeficiency virus type 1 infection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=408442

29 October 2018

Persistence of HIV-1 Transcription in Peripheral-Blood Mononuclear Cells in Patients Receiving Potent Antiretroviral Therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=408442

29 October 2018

Restricted antigenic variability of the epitope recognized by the neutralizing gp41 antibody 2F5

1 reference

https://pubmed.ncbi.nlm.nih.gov/10491418

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Absence of viral rebound after treatment of HIV-infected patients with didanosine and hydroxycarbamide

1 reference

https://pubmed.ncbi.nlm.nih.gov/10491418

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Studies reveal early impact of HIV infection, effects of treatment

1 reference

https://pubmed.ncbi.nlm.nih.gov/10491418

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Quantitation of HIV-1-Specific Cytotoxic T Lymphocytes and Plasma Load of Viral RNA

1 reference

https://pubmed.ncbi.nlm.nih.gov/10491418

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antiretroviral therapy in countries with low health expenditure

1 reference

https://pubmed.ncbi.nlm.nih.gov/10491418

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

HIV-1 suppression by early treatment with hydroxyurea, didanosine, and a protease inhibitor

1 reference

https://pubmed.ncbi.nlm.nih.gov/10491418

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

High rebound of plasma and cellular HIV load after discontinuation of triple combination therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/10491418

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

AIDS researchers target poor adherence

1 reference

https://pubmed.ncbi.nlm.nih.gov/10491418

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1172/JCI7371

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33853859&oldid=1982373596"